{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "23019254", "DateCompleted": {"Year": "2013", "Month": "02", "Day": "11"}, "DateRevised": {"Year": "2014", "Month": "11", "Day": "20"}, "Article": {"Language": ["eng"], "ELocationID": ["10.1136/thoraxjnl-2012-202628"], "ArticleDate": [{"Year": "2012", "Month": "09", "Day": "27"}], "Journal": {"ISSN": "1468-3296", "JournalIssue": {"Volume": "67", "Issue": "12", "PubDate": {"Year": "2012", "Month": "Dec"}}, "Title": "Thorax", "ISOAbbreviation": "Thorax"}, "ArticleTitle": "The president speaks: prevention is best: lessons from protecting the ozone layer.", "Pagination": {"StartPage": "1028", "EndPage": "1031", "MedlinePgn": "1028-31"}, "Abstract": {"AbstractText": ["The Montreal Protocol was signed 25 years ago. As a result, the irreversible destruction of the ozone layer was prevented. However, stratospheric ozone will not recover completely until 2060 and the consequent epidemic in skin cancer cases will persist until 2100. Many millions of patients with asthma and chronic obstructive pulmonary disease have safely switched from chlorofluorocarbon (CFC)-powered metered-dose inhalers (MDIs) to either hydrofluorocarbon (HFC) or DPIs. China will be the last country to phase out CFCs by 2016. HFCs are global warming gases which will be controlled in the near future. HFCs in MDIs may be phased out over the next 10-20 years."]}, "AuthorList": [{"AffiliationInfo": [], "Identifier": [], "LastName": "Woodcock", "ForeName": "Ashley", "Initials": "A"}], "PublicationTypeList": ["Editorial"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Thorax", "NlmUniqueID": "0417353", "ISSNLinking": "0040-6376"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Aerosol Propellants"}, {"RegistryNumber": "0", "NameOfSubstance": "Anti-Asthmatic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Chlorofluorocarbons"}, {"RegistryNumber": "0", "NameOfSubstance": "Stratospheric Ozone"}], "MeshHeadingList": [{"QualifierName": ["adverse effects", "chemistry"], "DescriptorName": "Aerosol Propellants"}, {"QualifierName": ["administration & dosage", "chemistry"], "DescriptorName": "Anti-Asthmatic Agents"}, {"QualifierName": ["drug therapy", "epidemiology"], "DescriptorName": "Asthma"}, {"QualifierName": ["adverse effects", "chemistry"], "DescriptorName": "Chlorofluorocarbons"}, {"QualifierName": ["legislation & jurisprudence"], "DescriptorName": "Environmental Pollution"}, {"QualifierName": [], "DescriptorName": "Global Health"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "International Cooperation"}, {"QualifierName": [], "DescriptorName": "Metered Dose Inhalers"}, {"QualifierName": ["drug therapy", "epidemiology"], "DescriptorName": "Pulmonary Disease, Chronic Obstructive"}, {"QualifierName": ["epidemiology"], "DescriptorName": "Skin Neoplasms"}, {"QualifierName": [], "DescriptorName": "Stratospheric Ozone"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2012", "Month": "9", "Day": "29", "Hour": "6", "Minute": "0"}, {"Year": "2012", "Month": "9", "Day": "29", "Hour": "6", "Minute": "0"}, {"Year": "2013", "Month": "2", "Day": "12", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["23019254", "10.1136/thoraxjnl-2012-202628", "thoraxjnl-2012-202628"]}}], "PubmedBookArticle": []}